Automated 3D planning for targeted cancer treatment
Official title: One-click Automated 3D Treatment Planning for Radiopharmaceutical Therapy
Funded at Voximetry, INC. · NIH-10909885 · Data updated 2026-11-12
This study is working on a smart tool that helps doctors create personalized radiation treatment plans for cancer patients, making sure each person gets just the right amount of radiation for their unique needs to improve their chances of recovery.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Voximetry, INC. NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | April 1, 2018 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $2,000,000 |
| NIH project number | 5R44CA221491-05 |
| Project ID | NIH-10909885 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients with metastatic prostate cancer, neuroendocrine tumors, or lymphoma who are undergoing radiopharmaceutical therapy.
✕Less likely to help
Patients with conditions not related to the targeted cancers or those not eligible for radiopharmaceutical therapy may not benefit from this research.
What this research studies
This research focuses on developing an automated system for personalized treatment planning in radiopharmaceutical therapy (RPT) for cancer patients. By utilizing advanced algorithms and artificial intelligence, the project aims to create a tool that can accurately model how radiation is absorbed in the body, allowing for tailored treatment doses based on individual patient characteristics. This approach seeks to improve treatment outcomes by ensuring that each patient receives the optimal amount of radiation for their specific condition. The system, known as Torch, integrates various features to enhance the planning process and is designed to be user-friendly for clinicians.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments, reducing side effects and improving patient outcomes.
How similar studies have gone: Previous research in personalized radiation therapy has shown promising results, indicating that tailored treatment plans can significantly improve patient outcomes.
Where this research is happening
-
Voximetry, INC.
Madison, United States Active
Researchers
- Principal investigator: Wickre, Paul — Voximetry, INC.
- Study coordinator: Wickre, Paul
Related research
Other NIH-funded projects on the same topics.
-
Faster, clearer SPECT scans to guide radiopharmaceutical cancer treatment
This project builds software that makes SPECT scans faster and clearer for people getting radiopharmaceutical cancer therapy.
-
A new software to improve SPECT imaging for personalized cancer treatment
This study is testing a new software called Torch Recon that helps make SPECT imaging clearer and more accurate, so patients with cancer can get better treatment plans based on their individual needs.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.